The Ghana National Chamber of Pharmacy has appealed to the government to reverse its decision to review the benchmark value on pharmaceutical products.
The Chamber warns if the value is reviewed, it will “lead to the increase of prices of medicines and other medical supplies”.
They are also warning the situation could lead to the high cost of healthcare delivery with its attendant cost implications on NHIS medicines.
“The affordability, accessibility, and improvement of patients care are the overriding objectives of the current benchmark policy for pharmaceutical products. The state loses on the removal of benchmark and the increase of final retail price it pays for medicines under the NHIA.”
“Therefore, the Ghana National Chamber of Pharmacy urges the government to reconsider its decision of removing the benchmark on pharmaceutical products”, the group’s statement added.
The appeal comes after the Ghana Revenue Authority had requested the government to cancel the discounts on Benchmark Values for vehicles and general goods from the 15th of November 2021.
The government in 2019, reduced the benchmark value or delivery values of imports, by 50%.
Vehicles were however reduced by 30%.
By: Rainbowradioonline.com/Ghana
